Martorana Davide, Vaglio Augusto, Greco Paolo, Zanetti Adele, Moroni Gabriella, Salvarani Carlo, Savi Mario, Buzio Carlo, Neri Tauro M
Laboratory of Molecular Genetiucs, Dept. of Clinical Medicine, Nephrology and Health Science, University of Parma, Via Gramsci 14, 43100 Parma, Italy.
Arthritis Rheum. 2006 Feb 15;55(1):126-30. doi: 10.1002/art.21698.
Patients with chronic periaortitis (CP) often show clinical and laboratory findings of a systemic autoimmune disorder. The aim of the present study was to investigate the role of the HLA system in CP.
Low-resolution genotyping for HLA-A, HLA-B, and HLA-DRB1 loci and genotyping of TNFA(-238)A/G and TNFA(-308)A/G single nucleotide polymorphisms were performed in 35 consecutive patients with CP and 350 healthy controls.
The HLA-DRB103 allele frequency was strikingly higher in patients with CP than in controls (24.28% versus 9.14%; chi(2) = 15.50, P = 0.000084, corrected P [P(corr)] = 0.0012, odds ratio [OR] 3.187, 95% confidence interval [95% CI] 1.74-5.83); the HLA-B08 allele frequency was also higher in patients than in controls (17.14% versus 6.28%; chi(2)=11.12, P = 0.0008, P(corr) = 0.0269, OR 3.085, 95% CI 1.54-6.16). The A01 allele frequency was significantly different (P = 0.0463), but the statistical significance was lost after correction for multiple testing (P(corr) = 0.5088). TNFA(-238)A allele and TNFA(-308)A allele frequencies were not significantly different (P = 0.512 and P = 0.445, respectively). Comparison of the main clinical and laboratory findings suggestive of a systemic autoimmune disease (e.g., acute-phase reactants, constitutional symptoms, other autoimmune diseases associated with CP) between the HLA-DRB103-positive and the HLA-DRB1*03-negative patients showed that the former group had significantly higher levels of C-reactive protein (P = 0.045) at disease onset, although this difference was not statistically significant after correction for multiple tests (P(corr) = 0.369).
The HLA system plays a role in susceptibility to CP. The strong association between CP and HLA-DRB1*03, an allele linked to a wide range of autoimmune conditions, further supports the view that CP may represent a clinical manifestation of an autoimmune disease.
慢性主动脉周炎(CP)患者常表现出系统性自身免疫性疾病的临床和实验室检查结果。本研究旨在探讨HLA系统在CP中的作用。
对35例连续的CP患者和350例健康对照进行HLA-A、HLA-B和HLA-DRB1基因座的低分辨率基因分型以及TNFA(-238)A/G和TNFA(-308)A/G单核苷酸多态性的基因分型。
CP患者中HLA-DRB103等位基因频率显著高于对照组(24.28%对9.14%;χ² = 15.50,P = 0.000084,校正P值[P(corr)] = 0.0012,优势比[OR] 3.187,95%置信区间[95% CI] 1.74 - 5.83);HLA-B08等位基因频率在患者中也高于对照组(17.14%对6.28%;χ² = 11.12,P = 0.0008,P(corr) = 0.0269,OR 3.085,95% CI 1.54 - 6.16)。A01等位基因频率有显著差异(P = 0.0463),但在多重检验校正后统计学意义消失(P(corr) = 0.5088)。TNFA(-238)A等位基因和TNFA(-308)A等位基因频率无显著差异(分别为P = 0.512和P = 0.445)。对HLA-DRB103阳性和HLA-DRB1*03阴性患者之间提示系统性自身免疫性疾病的主要临床和实验室检查结果(如急性期反应物、全身症状、与CP相关的其他自身免疫性疾病)进行比较,结果显示前一组在疾病发作时C反应蛋白水平显著更高(P = 0.045),尽管在多重检验校正后这种差异无统计学意义(P(corr) = 0.369)。
HLA系统在CP易感性中起作用。CP与HLA-DRB1*03(一种与多种自身免疫性疾病相关的等位基因)之间的强关联进一步支持了CP可能代表自身免疫性疾病临床表现的观点。